ARHGAP25 was mainly localized in the nucleus, and ARHGAP25 levels were decreased in lung cancer tissues (48.5%, 63/130; Fig. 2a) compared to paracancerous tissues (63.1%, 82/130; Fig. 2b). This evidence concerns the gene ARHGAP25 and lung carcinoma.